Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Sales (2016 - 2025)

Historic Return on Sales for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to 16.89%.

  • AC Immune's Return on Sales fell 171000.0% to 16.89% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.43%, marking a year-over-year decrease of 149700.0%. This contributed to the annual value of 1.86% for FY2024, which is 18000.0% up from last year.
  • Latest data reveals that AC Immune reported Return on Sales of 16.89% as of Q3 2025, which was down 171000.0% from 16.22% recorded in Q2 2025.
  • AC Immune's Return on Sales' 5-year high stood at 18745.0% during Q4 2022, with a 5-year trough of 8367.0% in Q1 2021.
  • Over the past 5 years, AC Immune's median Return on Sales value was 33.13% (recorded in 2024), while the average stood at 427.81%.
  • Per our database at Business Quant, AC Immune's Return on Sales surged by 187819300bps in 2022 and then crashed by -187595000bps in 2023.
  • AC Immune's Return on Sales (Quarter) stood at 36.93% in 2021, then skyrocketed by 50855bps to 18745.0% in 2022, then tumbled by -100bps to 14.5% in 2023, then increased by 4bps to 13.89% in 2024, then fell by -22bps to 16.89% in 2025.
  • Its Return on Sales stands at 16.89% for Q3 2025, versus 16.22% for Q2 2025 and 19.22% for Q1 2025.